Skip to main content
. 2023 Jul 14;23:659. doi: 10.1186/s12885-023-11156-y

Fig. 2.

Fig. 2

EGFR mutation, ALK and PD-L1 expression in adenocarcinoma according to the patients’ gender and smoking status